Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)

Clinical trial NCT06925984 · RECRUITING

Trial details

NCT number: NCT06925984
Sponsor: Jules Bordet Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

OligoProgressive Metastatic Disease

Start date: 2025-10-30
Primary completion: 2028-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.